Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Red Bull PET/CT.
Serfling SE, Buck A, Rowe SP, Higuchi T, Werner R. Serfling SE, et al. Among authors: rowe sp. Nuklearmedizin. 2024 Apr;63(2):76-77. doi: 10.1055/a-2195-0138. Epub 2023 Dec 22. Nuklearmedizin. 2024. PMID: 38134943 Free PMC article.
Prostate-specific Membrane Antigen: Diagnostics.
Alberts IL, Seifert R, Werner RA, Rowe SP, Afshar-Oromieh A. Alberts IL, et al. Among authors: rowe sp. PET Clin. 2024 Jul;19(3):351-362. doi: 10.1016/j.cpet.2024.03.001. Epub 2024 May 3. PET Clin. 2024. PMID: 38702228 Review.
Rate of unspecific bone uptake on PSMA PET is determined by the Scaffold - not the Radionuclide. Letter regarding: "The homunculus of unspecific bone uptakes associated with PSMA- targeted tracers: a systematic review-based definition" and "Cutting back on overdiagnosis - Occam's razor and unspecific bone uptakes in PSMA PET".
Rowe SP, Gorin MA. Rowe SP, et al. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3767-3768. doi: 10.1007/s00259-024-06897-2. Epub 2024 Sep 3. Eur J Nucl Med Mol Imaging. 2024. PMID: 39225824 No abstract available.
Clinical Factors Associated With Suspicious 18F-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography Activity in Patients Initially Managed With Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL.
Li EV, Bennett R 4th, Ho A, Wong C, Mahenthiran AK, Kumar SKSR, Sun Z, Savas H, Rowe SP, Schaeffer EM, Patel HD, Ross A. Li EV, et al. Among authors: rowe sp. J Urol. 2025 Feb;213(2):183-191. doi: 10.1097/JU.0000000000004298. Epub 2024 Oct 18. J Urol. 2025. PMID: 39423052
448 results